ECL
54
5
UHS
50
4
MAT
41
2
FOXA
67
5
BXP
39
5
GD
42
4
OI
23
3
IVZ
42
13
GS
65
16
STZ
42
2
HCP
54
2
GRMN
53
3
SLB
41
2
STX
34
2
HBI
53
4
SWK
53
4
HOG
29
4
KLAC
45
3
HUM
25
4
DOW
47
4
ECL
54
5
UHS
50
4
MAT
41
2
FOXA
67
5
BXP
39
5
GD
42
4
OI
23
3
IVZ
42
13
GS
65
16
STZ
42
2
HCP
54
2
GRMN
53
3
SLB
41
2
STX
34
2
HBI
53
4
SWK
53
4
HOG
29
4
KLAC
45
3
HUM
25
4
DOW
47
4
Financhill
Back

Komax Holding AG 10K Form

Sell
33

KMAAF
Komax Holding AG

Last Price:
$122.35
Seasonality Move:
-2.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KMAAF News And Ratings

See the #1 stock for the next 7 days that we like better than KMAAF

KMAAF Financial Statistics

Sales & Book Value

Annual Sales: $845.8M
Cash Flow: $0
Price / Cash Flow: 15.97
Annual Sales: $84.10
Price / Book: 1.45

Profitability

EPS (TTM): 1.24140
Net Income (TTM): $6.4M
Gross Margin: $526.7M
Return on Equity: 1.41%
Return on Assets: 0.77%

Komax Holding AG Earnings Forecast

Key Komax Holding AG Financial Ratios

  • The Gross Profit Margin over the past 22 years for KMAAF is 62.27%.
  • The Selling, General & Administrative Expenses for KMAAF have been equal to 6.62% of Gross Profit Margin.
  • The Research & Development expenses have been 1.47% of Revenue.
  • The Interest Expense is 13.45% of Operating Income.
  • The Net Earning history of KMAAF is 5.77% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 14 years.

Komax Holding AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Machinery
Sector: Industrials
Current Symbol: KMAAF
Website: komaxgroup.com

Debt

Debt-to-Equity Ratio: 0.46
Current Ratio: 3.23
Quick Ratio: 1.83

Price-to-Earnings

Trailing P/E Ratio: 12.88
Forward P/E Ratio: 0

KMAAF Technical Analysis vs Fundamental Analysis

Sell
33
Komax Holding AG (KMAAF) is a Sell

Is Komax Holding AG a Buy or a Sell?

  • Komax Holding AG stock is rated a Sell
    The current Komax Holding AG [KMAAF] share price is $122.35. The Score for KMAAF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.